BEIJING (CHINA) – Chinese state broadcaster CCTV said on Wednesday that a coronavirus vaccine which is being developed by China National Pharmaceutical Group (Sinopharm) could be ready for use by the end of this year.
The firm’s chairman Liu Jingzhen said they hope to finish late-stage human testing within three months.
In June, Sinopharm’s unit China National Biotec Group (CNBG), which is in charge of two COVID-19 vaccine projects, said the shot may not be ready until 2021, citing the lack of new infections in the country which has made testing difficult.
However, the firm overcame obstacles by finding alternative trial sites abroad. It is gunning to be the first in the global race for a vaccine.
Its vaccine has reached the Phase III trial that involves around 15,000 participants and two vaccine strains in the United Arab Emirates.
(Photos syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field